AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2016
Nov 21, 2016
29828_dirs_2016-11-21_8ff6ef21-bd53-48ce-9e68-dfb7fbdc48db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-11-10
Reporting Person: Meyers James R (EVP Worldwide Commercial Ops)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6726 | Direct |
| Common Stock | 121151 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) | $21.00 | 2017-10-22 | Common Stock (60000) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $21.575 | 2018-01-30 | Common Stock (100000) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $23.60 | 2019-01-21 | Common Stock (60000) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $24.905 | 2019-07-29 | Common Stock (60000) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $23.755 | 2020-01-28 | Common Stock (53200) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $19.085 | 2021-01-20 | Common Stock (67200) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $24.295 | 2022-01-26 | Common Stock (48000) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $40.56 | 2023-02-01 | Common Stock (34890) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $80.65 | 2024-02-01 | Common Stock (25780) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $104.83 | 2025-02-01 | Common Stock (17590) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $84.05 | 2026-02-01 | Common Stock (17560) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $78.90 | 2026-08-10 | Common Stock (15450) | Direct | |
| Restricted Stock Unit | $ | Common Stock (9780) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
F3: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F4: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.